How transplant oncology is rewriting the story of liver cancer
Transplant oncology is emerging as a transformative approach to treating liver cancer by replacing diseased organs rather than just removing tumors. This method allows doctors to treat multifocal cancer and scarred liver tissue simultaneously, provided patients meet specific biological criteria.
Why it matters
This medical advancement offers a potential cure for patients previously considered ineligible for surgery, significantly improving survival outcomes for aggressive liver cancers.
The liver is a large, forgiving organ, but tumours can grow deep within it, spread across both its halves, or take root in a liver already scarred by disease. Up until recently, cutting out the cancer was often impossible without leaving too little healthy liver behind to keep a person alive. Today, however, a growing field known as transplant oncology is changing that.
Instead of trying to cut the cancer out of the liver, doctors remove the entire diseased liver and replace it with a healthy one. The most common type of liver cancer, hepatocellular carcinoma (HCC), is frequently multifocal, meaning it appears in several places at once. A transplant solves both problems in a single operation: it removes every tumour, eliminates the scarred field that keeps producing them, and restores completely normal liver function.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in